Correlation Between Arrowhead Pharmaceuticals and Abcellera Biologics

Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arrowhead Pharmaceuticals and Abcellera Biologics, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and Abcellera Biologics.

Diversification Opportunities for Arrowhead Pharmaceuticals and Abcellera Biologics

0.23

Correlation Coefficient

Arrowhead Pharmaceuticals  Abcellera Biologics

Modest diversification

The 3 months correlation between Arrowhead and Abcellera is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and Abcellera Biologics go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and Abcellera Biologics

Given the investment horizon of 90 days Arrowhead Pharmaceuticals is expected to generate 10.77 times less return on investment than Abcellera Biologics. But when comparing it to its historical volatility, Arrowhead Pharmaceuticals is 1.54 times less risky than Abcellera Biologics. It trades about 0.02 of its potential returns per unit of risk. Abcellera Biologics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  271.00  in Abcellera Biologics on October 20, 2024 and sell it today you would earn a total of  26.00  from holding Abcellera Biologics or generate 9.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Arrowhead Pharmaceuticals  vs.  Abcellera Biologics

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Arrowhead Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Arrowhead Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Abcellera Biologics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Arrowhead Pharmaceuticals and Abcellera Biologics

The main advantage of trading using opposite Arrowhead Pharmaceuticals and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.

The idea behind Arrowhead Pharmaceuticals and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.